Please be advised that ITL’s last day of trading on the ASX will be Friday 8th February 2019

Innovating to
Make Life Easier

Find out how >

Essentials for Blood Management and Clinical Procedures

ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.
ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis. Read More

Direct-to-Consumer Pathology Testing Services

ITL offers MyHealthTest, a highly innovative consumer-based pathology testing service that allows individuals to order tests online or from pharmacies, prepare samples at home and have results delivered electronically.
ITL offers MyHealthTest, a highly innovative consumer-based pathology testing service that allows individuals to order tests online or from pharmacies, prepare samples at home and have results delivered electronically. Read More

Latest News

  • Company to delist from the ASX last trading day 8th February 2019 Read More
  • ITL Health Group Limited January 2019 Extraordinary General Meeting Results Read More
  • Voluntary Delisting from ASX—ITL Health Group Limited (ASX:ITD) Read More
  • ITL Health Group Announces 2017/18 Results Read More
  • ITL Health Group Featured on Biotech Daily Read More